Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Sumitomo Dainippon Pharma Co Ltd (DNPUF)
OTHER OTC:DNPUF
RESEARCH TOOLSreports
Holding DNPUF?
Track your performance easily
DNPUF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.73 - $5.12
Previous Close$3.79
Volume500.00
Average Volume (3M)5.53K
Market Cap
$1.55B
Enterprise Value$1.71B
Total Cash (Recent Filing)¥288.26B
Total Debt (Recent Filing)¥249.71B
Price to Earnings (P/E)―
Beta0.46
Next Earnings
Jan 30, 2025EPS Estimate
$0.27Last Dividend Ex-Date
Mar 30, 2023Dividend YieldN/A
Share Statistics
EPS (TTM)-4.75
Shares OutstandingN/A
10 Day Avg. Volume992
30 Day Avg. Volume5,533
Standard Deviation0.15
R-Squared0.03
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)0.55
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$3.90Price Target Upside2.63% Upside
Rating ConsensusModerate Sell
Number of Analyst Covering2
Sumitomo Dainippon Pharma Co News
PremiumCompany Announcements
Sumitomo Dainippon Pharma Reports Improved Financials
PremiumCompany Announcements
Sumitomo Pharma Streamlines Workforce with Retirement Program
PremiumCompany Announcements
Sumitomo Pharma Reports Significant Forex Losses
PremiumCompany Announcements
Sumitomo Pharma Initiates Early Retirement ProgramPremiumCompany Announcements
Sumitomo Pharma Records Robust Q1 Finance Income
PremiumCompany Announcements
Sumitomo Dainippon Pharma Projects Q1 FY2024 OutlookOptions Prices
Currently, No data available
---
Ownership Overview
―
Insiders
1.49% Mutual Funds
― Other Institutional Investors
95.84% Public Companies and
Individual Investors
DNPUF FAQ
What was Sumitomo Dainippon Pharma Co Ltd’s price range in the past 12 months?
Sumitomo Dainippon Pharma Co Ltd lowest stock price was $1.73 and its highest was $5.12 in the past 12 months.
What is Sumitomo Dainippon Pharma Co Ltd’s market cap?
Currently, no data Available
When is Sumitomo Dainippon Pharma Co Ltd’s upcoming earnings report date?
Sumitomo Dainippon Pharma Co Ltd’s upcoming earnings report date is Jan 30, 2025 which is in 69 days.
How were Sumitomo Dainippon Pharma Co Ltd’s earnings last quarter?
Sumitomo Dainippon Pharma Co Ltd released its earnings results on Oct 30, 2024. The company reported -$0.783 earnings per share for the quarter, missing the consensus estimate of $0.116 by -$0.899.
Is Sumitomo Dainippon Pharma Co Ltd overvalued?
According to Wall Street analysts Sumitomo Dainippon Pharma Co Ltd’s price is currently Undervalued.
Does Sumitomo Dainippon Pharma Co Ltd pay dividends?
Sumitomo Dainippon Pharma Co Ltd pays a Annually dividend of $0.05 which represents an annual dividend yield of N/A. See more information on Sumitomo Dainippon Pharma Co Ltd dividends here
What is Sumitomo Dainippon Pharma Co Ltd’s EPS estimate?
Sumitomo Dainippon Pharma Co Ltd’s EPS estimate is $0.27.
How many shares outstanding does Sumitomo Dainippon Pharma Co Ltd have?
Sumitomo Dainippon Pharma Co Ltd has 397,900,150 shares outstanding.
What happened to Sumitomo Dainippon Pharma Co Ltd’s price movement after its last earnings report?
Sumitomo Dainippon Pharma Co Ltd reported an EPS of -$0.783 in its last earnings report, missing expectations of $0.116. Following the earnings report the stock price went down -14.039%.
Which hedge fund is a major shareholder of Sumitomo Dainippon Pharma Co Ltd?
Currently, no hedge funds are holding shares in DNPUF
---
Sumitomo Dainippon Pharma Co Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
18.80%
12-Months-Change
Fundamentals
Return on Equity
-106.03%
Trailing 12-Months
Asset Growth
-27.38%
Trailing 12-Months
Company Description
Sumitomo Dainippon Pharma Co Ltd
Sumitomo Dainippon Pharma Co Ltd is a specialty and generic drug manufacturing company. Sumitomo's vast majority of sales are generated in North America, followed by Japan. The company's core business is its pharmaceutical products business. The pharmaceutical business maintains a focus on a variety of areas, including cardiovascular/diabetes, psychiatry & neurology, and specialty areas. Sumitomo considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
---
DNPUF Stock 12 Month Forecast
Average Price Target
$3.90
▲(2.63% Upside)
Technical Analysis
Best Analysts Covering DNPUF
1 Year
1 Year Success Rate
1/1 ratings generated profit
1 Year Average Return
+4.50%
downgraded a sell rating 25 days ago
Copying Hidemaru Yamaguchi's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +4.50% per trade.
---